Skip to content

NEPHROS MEDICAL

Active Private limited companyfounded 2007active for 19 yearsRue Abbé Coopmans 1, 4367 CrisnéeKBO/BCE: BE 0887.718.165

Lifetime

19 annual accounts with figures on one time axis
peak of €134,378 in 2025
€134,378▲ 12.8%
lowest -€3,028 in 2018
€87,838▲ 13.5%
peak of €355,513 in 2024
€347,138▼ 2.4%
€178,342▲ 149%
Board2 names since 2007
2 directors and 1 other
Documentsfilings and deeds
30-07-20261 day before the deadline
2025micro format
Gross margin from €119,114 to €134,378Dividend €102,837Debts from €71,761 to €178,342Cash from €344,383 to €236,891

Key points

from the 2025 annual accounts

Equity

€347,138 ▼ 2.4%
355,5132024+87,838Profit-102,837Dividend+6,624Other347,1382025

NEPHROS MEDICAL paid out €102,837 in dividends. That is 117% of the 2025 profit.

Debts

€178,342 ▲ 149%
Other debts
+95,940
Taxes and wages
+12,134
The rest
-1,493

Debts rose by €106,581 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.

Filings

19 annual accounts since 2007
AprilJune31 JulyOctober2010201520202025

Seven of the last ten came late. The 2019 accounts came in latest, 31 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,827 companies had the same profile as NEPHROS MEDICAL has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,827 companies, not a prediction for NEPHROS MEDICAL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director
  • all the sharesdeed of 12-12-2023
Board & ownership

Recent changes

Registered office moved from Oreye to Crisnée The registered office moved from Rue de Waremme 6, 4360 Oreye to Rue Abbé Coopmans numéro 1, 4367 Crisnée · changes role from manager to director · Registered office in the articles: Rue Abbé Coopmans 1, 4367 Crisnée · General meeting of 05-12-2023 · Gazette deed
Registered office moved from Crisnée to Oreye The registered office moved from RUE NESTOR ROYER 6 4637 CRISNEE to RUE DE Waremme, 6 à 4360 OREYE (Bergilers) · General meeting of 15-12-2014 · Gazette deed
Incorporation Founded by · Founding capital of €18,600, 186 shares, €12,400 paid up · appointed as manager · published on 14-03-2007 · Gazette deed
All 32 events

Official details

Source: KBO
Status
Active since 06-03-2007Normal situation
Activity
“Les honoraires sont perçus par et pour la société” (deed in French)From the articles, 7 activitiesNo NACE code in the KBO
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

≈ €330,000estimated
€525,481▲ 23.0%
Filing
Filed on 30-07-2026, 1 day before the end of the filing period
Financials

Insights on NEPHROS MEDICAL

NEPHROS MEDICAL files the micro format. That format states no turnover. The gross margin rose from €36,730 in 2007 to €134,378 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NEPHROS MEDICAL

What is the company number of NEPHROS MEDICAL?
The company number of NEPHROS MEDICAL is 0887.718.165. The VAT number is the same number with BE in front: BE 0887.718.165.
Where is NEPHROS MEDICAL based?
The registered office is at Rue Abbé Coopmans 1, 4367 Crisnée.Company details
What is the legal form of NEPHROS MEDICAL?
NEPHROS MEDICAL is a private limited company (BV).
When was NEPHROS MEDICAL founded?
NEPHROS MEDICAL was founded on 06-03-2007.
Is NEPHROS MEDICAL still active?
Yes, NEPHROS MEDICAL is an active enterprise in the KBO register.
What is the turnover of NEPHROS MEDICAL?
The turnover in financial year 2025 is about €330,000. This figure is estimated from the gross margin of €134,378 and 2,451 comparable companies of the same size. It probably lies between €220,000 and €520,000. It is a rough estimate.Financials
Is NEPHROS MEDICAL profitable?
In financial year 2025, NEPHROS MEDICAL made a profit of €87,838.
Where can I find the annual accounts of NEPHROS MEDICAL?
NEPHROS MEDICAL filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NEPHROS MEDICAL due?
NEPHROS MEDICAL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.